Your browser doesn't support javascript.
Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.
Katowa, Ben; Kalonda, Annie; Mubemba, Benjamin; Matoba, Japhet; Shempela, Doreen Mainza; Sikalima, Jay; Kabungo, Boniface; Changula, Katendi; Chitanga, Simbarashe; Kasonde, Mpanga; Kapona, Otridah; Kapata, Nathan; Musonda, Kunda; Monze, Mwaka; Tembo, John; Bates, Matthew; Zumla, Alimuddin; Sutcliffe, Catherine G; Kajihara, Masahiro; Yamagishi, Junya; Takada, Ayato; Sawa, Hirofumi; Chilengi, Roma; Mukonka, Victor; Muleya, Walter; Simulundu, Edgar.
  • Katowa B; Macha Research Trust, Choma 20100, Zambia.
  • Kalonda A; Department of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.
  • Mubemba B; Department of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka 10101, Zambia.
  • Matoba J; Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.
  • Shempela DM; Africa Centre of Excellence for Infectious Diseases of Humans and Animals, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.
  • Sikalima J; Department of Wildlife Sciences, School of Natural Resources, Copperbelt University, Kitwe 50100, Zambia.
  • Kabungo B; Department of Biomedical Sciences, School of Medicine, Copperbelt University, Ndola 50100, Zambia.
  • Changula K; Macha Research Trust, Choma 20100, Zambia.
  • Chitanga S; Churches Health Association of Zambia, Lusaka 10101, Zambia.
  • Kasonde M; Churches Health Association of Zambia, Lusaka 10101, Zambia.
  • Kapona O; Southern Provincial Health Office, Ministry of Health, Choma 20100, Zambia.
  • Kapata N; Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.
  • Musonda K; Department of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka 10101, Zambia.
  • Monze M; Department of Preclinical Studies, School of Veterinary Medicine, University of Namibia, Windhoek Private Bag 13301, Namibia.
  • Tembo J; School of Life Sciences, College of Agriculture, Engineering and Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
  • Bates M; Zambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
  • Zumla A; Zambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
  • Sutcliffe CG; Zambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
  • Kajihara M; Zambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
  • Yamagishi J; Virology Laboratory, University Teaching Hospital, Lusaka 10101, Zambia.
  • Takada A; HerpeZ Infection Research and Training, University Teaching Hospital, Lusaka 10101, Zambia.
  • Sawa H; HerpeZ Infection Research and Training, University Teaching Hospital, Lusaka 10101, Zambia.
  • Chilengi R; School of Life and Environmental Sciences, University of Lincoln, Lincoln, Lincolnshire LN6 7TS, UK.
  • Mukonka V; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London NW3 2PF, UK.
  • Muleya W; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
  • Simulundu E; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Viruses ; 14(9)2022 08 24.
Article in English | MEDLINE | ID: covidwho-1997812
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have significantly impacted the global epidemiology of the pandemic. From December 2020 to April 2022, we conducted genomic surveillance of SARS-CoV-2 in the Southern Province of Zambia, a region that shares international borders with Botswana, Namibia, and Zimbabwe and is a major tourist destination. Genetic analysis of 40 SARS-CoV-2 whole genomes revealed the circulation of Alpha (B.1.1.7), Beta (B.1.351), Delta (AY.116), and multiple Omicron subvariants with the BA.1 subvariant being predominant. Whereas Beta, Delta, and Omicron variants were associated with the second, third, and fourth pandemic waves, respectively, the Alpha variant was not associated with any wave in the country. Phylogenetic analysis showed evidence of local transmission and possible multiple introductions of SARS-CoV-2 VOCs in Zambia from different European and African countries. Across the 40 genomes analysed, a total of 292 mutations were observed, including 182 missense mutations, 66 synonymous mutations, 23 deletions, 9 insertions, 1 stop codon, and 11 mutations in the non-coding region. This study stresses the need for the continued monitoring of SARS-CoV-2 circulation in Zambia, particularly in strategically positioned regions such as the Southern Province which could be at increased risk of introduction of novel VOCs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Year: 2022 Document Type: Article Affiliation country: V14091865

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Year: 2022 Document Type: Article Affiliation country: V14091865